UBS Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.56M | Sell |
|
|||||
|
2025
Q2 | $4.23M | Buy |
|
|||||
|
2025
Q1 | $4.87M | Buy |
|
|||||
|
2024
Q4 | $6.55M | Buy |
|
|||||
|
2024
Q3 | $5.59M | Buy |
|
|||||
|
2024
Q2 | $2.98M | Sell |
|
|||||
|
2024
Q1 | $4.48M | Buy |
|
|||||
|
2023
Q4 | $3.23M | Buy |
|
|||||
|
2023
Q3 | $1.13M | Sell |
|
|||||
|
2023
Q2 | $2.56M | Buy |
|
|||||
|
2023
Q1 | $1.78M | Sell |
|
|||||
|
2022
Q4 | $2.67M | Buy |
|
|||||
|
2022
Q3 | $664K | Sell |
|
|||||
|
2022
Q2 | $690K | Sell |
|
|||||
|
2022
Q1 | $3.55M | Sell |
|
|||||
|
2021
Q4 | $5.02M | Buy |
|
|||||
|
2021
Q3 | $3.22M | Buy |
|
|||||
|
2021
Q2 | $353K | Sell |
|
|||||
|
2021
Q1 | $3.27M | Buy |
|
|||||
|
2020
Q4 | $1.73M | Buy |
|
|||||
|
2020
Q3 | $172K | Buy |
|
|||||
|
2020
Q2 | $97K | Sell |
|
|||||
|
2020
Q1 | $502K | Sell |
|
|||||
|
2019
Q4 | $1.85M | Sell |
|
|||||
|
2019
Q3 | $5.11M | Buy |
|
|||||
|
2019
Q2 | $542K | Buy |
|
|||||
|
2019
Q1 | $615K | Sell |
|
|||||
|
2018
Q4 | $5.53M | Buy |
|
|||||
|
2018
Q3 | $878K | Sell |
|
|||||
|
2018
Q2 | $805K | Sell |
|
|||||
|
2018
Q1 | $4.32M | Buy |
|
|||||
|
2017
Q4 | $1.38M | Buy |
|
|||||
|
2017
Q3 | $1.36M | Sell |
|
|||||
|
2017
Q2 | $1.48M | Sell |
|
|||||
|
2017
Q1 | $2.38M | Sell |
|
|||||
|
2016
Q4 | $2.62M | Buy |
|
|||||
|
2016
Q3 | $2.2M | Buy |
|
|||||
|
2016
Q2 | $2.95M | Buy |
|
|||||
|
2016
Q1 | $788K | Sell |
|
|||||
|
2015
Q4 | $1.15M | Sell |
|
|||||
|
2015
Q3 | $3.02M | Buy |
|
|||||
|
2015
Q2 | $2.54M | Buy |
|
|||||
|
2015
Q1 | $1.22M | Sell |
|
|||||
|
2014
Q4 | $2.34M | Buy |
|